Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.

× No keyword cloud information.

7 in total

Review 1. Intravenous immunoglobulin therapy in neurological diseases during pregnancy.

Authors: Isabel Ringel; Uwe K Zettl
Journal: J Neurol Date: 2006-09 Impact factor: 4.849

Review 2. Intravenous immunoglobulin in neurological disease: a specialist review.

Authors: C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal: J Neurol Neurosurg Psychiatry Date: 2002-04 Impact factor: 10.154

Review 3. Lambert-Eaton myasthenic syndrome.

Authors: U Seneviratne; R de Silva
Journal: Postgrad Med J Date: 1999-09 Impact factor: 2.401

4. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.

Authors: M Uchuya; F Graus; F Vega; R Reñé; J Y Delattre
Journal: J Neurol Neurosurg Psychiatry Date: 1996-04 Impact factor: 10.154

Review 5. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.

Authors: Isabel Illa
Journal: J Neurol Date: 2005-05 Impact factor: 4.849

Review 6. Treatment for Lambert-Eaton myasthenic syndrome.

Authors: Michael Keogh; Saam Sedehizadeh; Paul Maddison
Journal: Cochrane Database Syst Rev Date: 2011-02-16

Review 7. Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome.

Authors: Tyler B Tarr; Peter Wipf; Stephen D Meriney
Journal: Mol Neurobiol Date: 2014-09-09 Impact factor: 5.590

7 in total